Breaking News

Capsugel Expands LMP Drug Delivery Platform

New technology offers bioavailability enhancement and modified release suites

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Capsugel’s lipid multi-particulate (LMP) technology drug delivery platform is now commercially available for multiple applications, including bioavailability enhancement, taste-masking and modified release for pharmaceutical and health and nutrition products. The company’s LMP technology is based on its melt-spray congeal (MSC) processing and combines lipid-based formulations (LBF) with the functionality of a multi-particulate dosage form in one offering.   MSC processing for LMP production is c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters